echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Shanghai issued a new notice on volume purchase, and the replacement of selected drugs and the replacement of non selected drugs began to accelerate

    Shanghai issued a new notice on volume purchase, and the replacement of selected drugs and the replacement of non selected drugs began to accelerate

    • Last Update: 2019-12-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [industry trends of pharmaceutical network] recently, Shanghai Medical Insurance released the notice on continuing to do a good job in the work related to volume purchase of medical insurance drugs in Shanghai, requiring some hospitals to speed up the procurement of selected drugs in volume purchase It is clearly stated that all non-profit medical institutions and designated medical institutions of medical insurance in the city should simplify and speed up the procurement process if they have already purchased other enterprises of the same variety but have not previously purchased the selected enterprise varieties At the same time, it is pointed out that the city's designated retail pharmacies for medical insurance should refer to the priority purchase and sales volume purchase of selected drugs by medical institutions In addition, it is also mentioned that for other drugs purchased in volume, if the quality and efficacy of the drugs not selected are guaranteed, and the price is appropriate, the medical institutions can continue to purchase the drugs selected in priority, but the quantity shall not exceed the selected drugs, which shall be deemed to meet the requirements of "one product, two regulations" In fact, in January, the national health and Health Commission, the medical administration and the medical administration issued a notice, requiring the national organization to do a good job in the centralized purchase of selected drugs in the clinical allocation and use, and standardizing the use of "4 + 7" selected drugs from the perspective of clinical use, to ensure the dosage It can be foreseen that the state will strongly support and promote the centralized purchase of selected drugs At present, the reform of health insurance has achieved initial results Earlier, the pilot results of centralized procurement of drugs organized by the state announced by Guangzhou showed that by the end of August, the total procurement of selected varieties in Guangzhou accounted for about 80% of the planned procurement, and the total procurement of selected varieties accounted for 88% of the same generic drugs And the amount only accounts for 57%, saving more than 160 million yuan for medical insurance and personal expenses On October 30, the Information Office of Shenyang Municipal People's government held a press conference to summarize the relevant drug procurement since the city launched the pilot work of centralized drug procurement and use organized by the state Among them, it should be noted that the alternative effect of the selected drugs is obvious The total purchase amount of selected drugs reached 52.77 million tablets (granules / tablets), 6 times of the total purchase amount of 9.2 million tablets (granules / tablets) of unselected drugs under the same general name, accounting for more than 85% of the purchase amount of drugs under the same general name Moreover, it is not only Shenyang, but also Guangzhou, Jiangxi and other pilot cities that have released the implementation of volume procurement successively From this point of view, the proportion of the procurement volume of selected drugs in the procurement volume of generic drugs of the same kind is also more than 80% This figure is obviously higher than 60% to 70% of the original design It can be seen that the implementation of centralized drug procurement with volume brings huge benefits to the masses and the results of price reduction In general, in combination with the more complete supporting rules of volume purchase, the continuous upgrading of supervision means such as clinical fee control and anti-corruption storm, and the implementation of the reform of medical insurance payment mode, it has become the independent choice of medical institutions to choose the medium-sized drugs with higher cost performance In addition, as soon as the policy of increasing the proportion of patients' out of pocket payment is put forward, the patients will also make their own choice after increasing the proportion of patients' out of pocket payment It can be foreseen that in the future, if we want to strive for the remaining 30% - 40% of the market share of the unselected drugs, especially the imported original research drugs, the price reduction will become inevitable Therefore, some insiders said that under the general purpose of the medical reform, such as "vacating cages and changing birds", with the expansion of 4 + 7, the scope of clinical substitution of unselected drugs may soon expand to the whole country, and the tide of drug price reduction is expected to come soon.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.